FOLFIRI-Bevacizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, fluorouracil, irinotecan and leucovorin that may be used in the treatment of ampullary and appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Bevacizumab + IFL - FOLFIRI and Bevacizumab - FOLFIRI and Bevacizumab (L-Leucovorin) - FOLFIRI and Bevacizumab-adcd - FOLFIRI and Bevacizumab-adcd (L-Leucovorin) - FOLFIRI and Bevacizumab-awwb - FOLFIRI and Bevacizumab-awwb (L-Leucovorin) - FOLFIRI and Bevacizumab-aybi - FOLFIRI and Bevacizumab-aybi (L-Leucovorin) - FOLFIRI and Bevacizumab-bvzr - FOLFIRI and Bevacizumab-bvzr (L-Leucovorin) - FOLFIRI and Bevacizumab-equi - FOLFIRI and Bevacizumab-equi (L-Leucovorin) - FOLFIRI and Bevacizumab-maly - FOLFIRI and Bevacizumab-maly (L-Leucovorin) - FOLFIRI and Bevacizumab-onbe - FOLFIRI and Bevacizumab-onbe (L-Leucovorin) - FOLFIRI and Bevacizumab-tnjn - FOLFIRI and Bevacizumab-tnjn (L-Leucovorin) - FOLFIRI-Avastin Regimen - FOLFIRI-Avastin regimen - FOLFIRI-bevacizumab regimen - FOLFIRI/Bevacizumab Regimen - Folinic Acid-Fluorouracil-Irinotecan-Bevacizumab Regimen